Cardiovascular autonomic dysfunction in primary ovarian insufficiency: Clinical and experimental evidence

American Journal of Translational Research

Volumn 6, Issue 1, 2014, Pages 91-101

  Goldmeier, Silvia ^a   De Angelis, Kátia ^b   Casali, Karina Rabello ^a   Vilodre, César ^c   Consolim Colombo, Fernanda ^d   Klein, Adriane Belló ^e   Plentz, Rodrigo ^f   Spritzer, Polimara ^c,e   Irigoyen, Maria Cláudia ^a,d  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Autonomic nervous system; Endothelium; Hormones; Oxidative stress; Primary ovarian insufficiency; Rats; Women

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHROPOMETRY; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MEASUREMENT; BRACHIAL FLOW MEDIATED VASODILATION; CARDIOVASCULAR AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART RATE VARIABILITY; HEMODYNAMIC PARAMETERS; HORMONAL THERAPY; HUMAN; LIPID PEROXIDATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PREMATURE OVARIAN FAILURE; PRESSORECEPTOR REFLEX; RAT; RR INTERVAL; VASCULAR VASODILATATION ATTENUATION; VASODILATATION;

EID: 84889633783     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Goswami D and Conway GS. Premature ovarian failure. Horm Res 2007; 68: 196-202.
2. Coulam CB, Adamson SC and Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67: 604-606.
3. Jacobsen BK, Knutsen SF and Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: The adventist health study. J Clin Epidemiol 1999; 52: 303-307.
4. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, Rosner B and Stampfer MJ. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159: 1061-1066.
5. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A and Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Atrami (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 1998; 351: 478-484.
6. Li Z, Mao HZ, Abboud FM and Chapleau MW. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 1996; 79: 802-811.
7. Studinger P, Mersich B, Lenard Z, Somogyi A and Kollai M. Effect of vitamin e on carotid artery elasticity and baroreflex gain in young, healthy adults. Auton Neurosci 2004; 113: 63-70.
8. Irigoyen MC, Paulini J, Flores LJ, Flues K, Bertagnolli M, Moreira ED, Consolim-Colombo F, Bello-Klein A and De Angelis K. Exercise training improves baroreflex sensitivity associated with oxidative stress reduction in ovariectomized rats. Hypertension 2005; 46: 998-1003.
9. Bertagnolli M, Campos C, Schenkel PC, de Oliveira VL, De Angelis K, Bello-Klein A, Rigatto K and Irigoyen MC. Baroreflex sensitivity improvement is associated with decreased oxidative stress in trained spontaneously hypertensive rat. J Hypertens 2006; 24: 2437-2443.
10. Mercuro G, Podda A, Pitzalis L, Zoncu S, Mascia M, Melis GB and Rosano GM. Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am J Cardiol 2000; 85: 787-789.
11. Hernandez I, Delgado JL, Diaz J, Quesada T, Teruel MJ, Llanos MC and Carbonell LF. 17beta-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1599-1605.
12. Flues K, Paulini J, Brito S, Sanches IC, Consolim-Colombo F, Irigoyen MC and De Angelis K. Exercise training associated with estrogen therapy induced cardiovascular benefits after ovarian hormones deprivation. Maturitas 2010; 65: 267-271.
13. Benetti-Pinto CL, Bedone AJ and Magna LA. Evaluation of serum androgen levels in women with premature ovarian failure. Fertil Steril 2005; 83: 508-510.
14. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002; 39: 257-265.
15. Malliani A, Pagani M, Lombardi F and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
16. Montano N, Porta A, Cogliati C, Costantino G, Tobaldini E, Casali KR and Iellamo F. Heart rate variability explored in the frequency domain: A tool to investigate the link between heart and behavior. Neurosci Biobehav Rev 2009; 33: 71-80.
17. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
18. Marklund S and Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
19. Flores LJ, Figueroa D, Sanches IC, Jorge L and Irigoyen MC, Rodrigues B, De Angelis K. Effects of exercise training on autonomic dysfunction management in an experimental model of menopause and myocardial infarction. Menopause 2010; 17: 712-717.
20. Gonzalez Flecha B, Llesuy S and Boveris A. Hydroperoxide-initiaded chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle. Free Rad Biol Med 1991; 10: 1093-1100.
21. Lowry OH, Rosenbrough NT and Farr AL. Protein measurements with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. Herrington DM, Espeland MA, Crouse JR 3rd, Robertson J and Riley WA, McBurnie MA, Burke GL. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol 2001; 21: 1955-1961.
23. de Kleijn MJ, Wilmink HW, Bots ML, Bak AA, van der Schouw YT, Planellas J, Engelen S, Banga JD and Grobbee DE. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis 2001; 159: 357-365.
24. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, Paraskevaidis EA, Sideris DA, Tsatsoulis A, Chrousos GP and Michalis LK. Impaired endothelial function in young women with premature ovarian failure: Normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89: 3907-3913.
25. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A and Salvetti A. Age-related reduction of no availability and oxidative stress in humans. Hypertension 2001; 38: 274-279.
26. Chowdhary S and Townend JN. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci (Lond) 1999; 97: 5-17.
27. Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, Belló-Klein A and Singal P. Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz J Med Biol Res 2002; 35: 1075-1081.
28. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T and Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 1991; 88: 10045-10048.
29. Delgado JL, Landeras J, Carbonell LF, Parrilla JJ, Abad L, Quesada T, Fiol G and Hernandez I. Effect of n-acetyl-cysteine on vascular endothelelium function in aorta from oophorectomized rats. Gen Pharmacol 1998; 32: 23-27.
30. Wallin BG. Interindividual differences in muscle sympathetic nerve activity: a key to new insight into cardiovascular regulation? Acta Physiol (Oxf) 2007; 190: 265-75.
31. Meskhi A and Seif MW. Premature ovarian failure. Curr Opin Obstet Gynecol 2006; 18: 418-426
32. Heeren MV, De Sousa LE, Mostarda C, Moreira E, Machert H, Rigatto KV, Wichi RB, Irigoyen MC and De Angelis K. Exercise improves cardiovascular control in a model of dislipidemia and menopause. Maturitas 2009; 62: 200-204.
33. Moien-Afshari F, Kenyon E, Choy JC, Battistini B, McManus BM and Laher I. Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats. Maturitas 2003; 45: 213-223.
34. Du XJ, Riemersma RA and Dart AM. Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function. Circ Res 1995; 30: 161-165.
35. Du XJ, Dart AM, Riemersma RA and Oliver MF. Sex difference in presynaptic adrenergic inhibition of norepinephrine release during normoxia and ischemia in the rat heart. Circ Res 1991; 68: 827-835.
36. Mullan BA, Young IS, Fee H and McCance DR. Ascorbic acid reduces blood pressure and arterial stiffiness in type 2 diabetes. Hypertension 2002; 40: 804-809.
37. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065.
38. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 3: 321-333.
39. Hunt BE, Taylor JA, Hamner JW, Gagnon M and Lipsitz LA. Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women. Circulation 2001; 103: 2909-2914.